Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Evaluation of the Effectiveness and Safety of the RIGHTEST™ iFree 2 Continuous Glucose Monitoring System in Pregnant Women With Diabetes Mellitus
An Open-label, Multicenter, Randomized, Parallel-group Trial to Assess Glycemic Control With the RIGHTEST iFree 2 Continuous Glucose Monitoring System in Adults With Diabetes Mellitus
Effectiveness and Safety of the RIGHTEST™ Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)